[1]
|
Tan, L.T., Tanderup, K., Kirisits, C., de Leeuw, A., Nout, R., Duke, S., et al. (2019) Image-Guided Adaptive Radiotherapy in Cervical Cancer. Seminars in Radiation Oncology, 29, 284-298.
https://doi.org/10.1016/j.semradonc.2019.02.010
|
[2]
|
Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J. and Jemal, A. (2015) Global Cancer Statistics, 2012. CA: A Cancer Journal for Clinicians, 65, 87-108. https://doi.org/10.3322/caac.21262
|
[3]
|
Hong, J.H., Tsai, C.S., Wang, C.C., Lai, C.H., Chen, W.C., Lee, S.P., et al. (2000) Comparison of Clinical Behaviors and Responses to Radiation between Squamous Cell Carcinomas and Adenocarcinomas/Adenosquamous Carcinomas of the Cervix. Chang Gung Medical Journal, 23, 396-404.
|
[4]
|
Zhou, J., Wu, S.G., Sun, J.Y., Li, F.Y., Lin, H.X., Chen, Q.H., et al. (2017) Comparison of Clinical Outcomes of Squamous Cell Carcinoma, Adenocarcinoma, and Adenosquamous Carcinoma of the Uterine Cervix after Definitive Radiotherapy: A Population-Based Analysis. Journal of Cancer Research and Clinical Oncology, 143, 115-122.
https://doi.org/10.1007/s00432-016-2246-9
|
[5]
|
Chen, J.L., Huang, C.Y., Huang, Y.S., Chen, R.J., Wang, C.W., Chen, Y.H., et al. (2014) Differential Clinical Characteristics, Treatment Response and Prognosis of Locally Advanced Adenocarcinoma/Adenosquamous Carcinoma and Squamous Cell Carcinoma of Cervix Treated with Definitive Radiotherapy. Acta Obstetricia et Gynecologica Scandinavica, 93, 661-668. https://doi.org/10.1111/aogs.12383
|
[6]
|
Fu, S., Li, Z., Xiao, L.B., Hu, W.F., Zhan, L., Xie, B.W., et al. (2019) Glutamine Synthetase Promotes Radiation Resistance via Facilitating Nucleotide Metabolism and Subsequent DNA Damage Repair. Cell Reports, 28, 1136-1143.e4.
https://doi.org/10.1016/j.celrep.2019.07.002
|
[7]
|
Nambiar, M. and Raghavan, S.C. (2011) How Dose DNA Break during Chromosomal Translocations? Nucleic Acids Research, 39, 5813-5825. https://doi.org/10.1093/nar/gkr223
|
[8]
|
Pardo, B., Go’mez-Gonza’lez, B. and Aguilera, A. (2009) DNA Repair in Mammalian Cells: DNA Double-Strand Break Repair: How to Fix a Broken Relationship. Cellular and Molecular Life Sciences, 66, 1039-1056.
https://doi.org/10.1007/s00018-009-8740-3
|
[9]
|
王济东, 王俊杰. 低剂量率辐射生物效应的研究进展[J]. 国外医学(放射医学核医学分册), 2005, 29(4): 186-189.
http://dx.chinadoi.cn/10.3760/cma.j.issn.1673-4114.2005.04.013
|
[10]
|
Krajewski, W.W., Collins, R., Holmberg-Schiavone, L., Jones, T.A., Karlberg, T. and Mowbray, S.L. (2008) Crystal Structures of Mammalian Glutamine Synthetases Illustrate Substrate-Induced Conformational Changes and Provide Opportunities for Drug and Herbicide Design. Journal of Molecular Biology, 375, 217-228.
https://doi.org/10.1016/j.jmb.2007.10.029
|
[11]
|
Tardito, S., Oudin, A., Ahmed, S.U., Fack, F., Keunen, O., Zheng, L., Miletic, H., et al. (2015) Glutamine Synthetase Activity Fuels Nucleotide Biosynthesis and Supports Growth of Glutamine-Restricted Glioblastoma. Nature Cell Biology, 17, 1556-1568. https://doi.org/10.1038/ncb3272
|
[12]
|
Bott Alex, J., Peng, I.C., Fan, Y., Faubert, B., Zhao, L., Li, J., Neidler, S., Sun, Y., Jaber, N., Krokowski, D., et al. (2015) Oncogenic Myc Induces Expression of Glutamine Synthetase through Promoter Demethylation. Cell Metabolism, 22, 1068-1077. https://doi.org/10.1016/j.cmet.2015.09.025
|
[13]
|
Fluteau, A., Ince, P.G., Minett, T., Matthews, F.E., Brayne, C., Garwood, C.J., Ratcliffe, L.E., Morgan, S., Heath, P.R., Shaw, P.J., et al. (2015) The Nuclear Retention of Transcription Factor FOXO3a Correlates with a DNA Damage Response and Increased Glutamine Synthetase Expression by Astrocytes Suggesting a Neuroprotective Role in the Ageing Brain. Neuroscience Letters, 609, 11-17. https://doi.org/10.1016/j.neulet.2015.10.001
|
[14]
|
Turgeon, M., Perry, N.J.S. and Poulogiannis, G. (2018) DNA Damage, Repair, and Cancer Metabolism. Frontiers in Oncology, 8, 15. https://doi.org/10.3389/fonc.2018.00015
|
[15]
|
Wang, L., Peng, W., Wu, T.M., Deng, P.C. and Zhao, Y.L. (2018) Increased Glutamine Anabolism Sensitizes Non-Small Cell Lung Cancer to Gefitinib Treatment. Cell Death Discovery, 4, Article No. 84.
https://doi.org/10.1038/s41420-018-0086-x
|
[16]
|
Ye, J.X., Huang, Q., Xu, J., Huang, J.S., Wang, J.Z., Zhong, W.J., et al. (2018) Targeting of Glutamine Transporter ASCT2 and Glutamine Synthetase Suppresses Gastric Cancer Cell Growth. Journal of Cancer Research and Clinical Oncology, 144, 821-833. https://doi.org/10.1007/s00432-018-2605-9
|
[17]
|
Li, D.D., Fu, Z.Q., Chen, R.W., Zha, X.H., Zhou, Y., Zeng, B., et al. (2015) Inhibition of Glutamine Metabolism Counteracts Pancreatic Cancer Stem Cell Features and Sensitizes Cells to Radiotherapy. Oncotarget, 6, 31151-31163.
https://doi.org/10.18632/oncotarget.5150
|
[18]
|
Shi, X.C., Zhang, X.S., Yi, C., Liu, Y. and Qiao, H. (2014) [¹³N]Ammonia Positron Emission Tomographic/Computed Tomographic Imaging Targeting Glutamine Synthetase Expression in Prostate Cancer. Molecular Imaging, 13, 1-10.
https://doi.org/10.2310/7290.2014.00048
|
[19]
|
Karran, P. (2000) DNA Double Strand Break Repair in Mammalian Cells. Current Opinion in Genetics & Development, 10, 144-150. https://doi.org/10.1016/S0959-437X(00)00069-1
|
[20]
|
Zhang, Y.Y., He, Q., Hu, Z.Y., Feng, Y., Fan, L.L., Tang, Z.Q., et al. (2016) Long Noncoding RNA LINP1 Regulates Repair of DNA Double-Strand Breaks in Triple-Negative Breast Cancer. Nature Structural & Molecular Biology, 23, 522-530. https://doi.org/10.1038/nsmb.3211
|
[21]
|
Zlotorynski, E. (2016) Non-Coding RNA: LINP1 Joins Ends with Triple-Negative Effect. Nature Reviews Molecular Cell Biology, 17, 330-331. https://doi.org/10.1038/nrm.2016.60
|
[22]
|
Wang, X.X., Liu, H., Shi, L.M., Yu, X.L., Gu, Y.J. and Sun, X.N. (2018) LINP1 Facilitates DNA Damage Repair through Non-Homologous End Joining (NHEJ) Pathway and Subsequently Decreases the Sensitivity of Cervical Cancer Cells to Ionizing Radiation. Cell Cycle, 17, 439-447. https://doi.org/10.1080/15384101.2018.1442625
|
[23]
|
Liang, Y.R., Li, Y.M., Song, X.J., Zhang, N., Sang, Y.T., Zhang, H.W., et al. (2018) Long Noncoding RNA LINP1 Acts as an Oncogene and Promotes Chemoresistance in Breast Cancer. Cancer Biology & Therapy, 19, 120-131.
https://doi.org/10.1080/15384047.2017.1394543
|
[24]
|
Li, Y., Hou, C.Z., Dong, Y.-L., Zhu, L. and Xu, H. (2020) Long Noncoding RNA LINP1 Promoted Proliferation and Invasion of Ovarian Cancer via Inhibiting KLF6. European Review for Medical and Pharmacological Sciences, 24, 7918. https://doi.org/10.26355/eurrev_202008_22452
|
[25]
|
Campillo-Marcos, I. and Lazo, P.A. (2018) Implication of the VRK1 Chromatin Kinase in the Signaling Responses to DNA Damage: A Therapeutic Target? Cellular and Molecular Life Sciences, 75, 2375-2388.
https://doi.org/10.1007/s00018-018-2811-2
|
[26]
|
Hosseini, E.S., Meryet-Figuiere, M., Sabzalipoor, H., Haddad Kashani, H., Nikzad, H. and Asemi, Z. (2017) Dysregulated Expression of Long Noncoding RNAs in Gynecologic Cancers. Molecular Cancer, 16, Article No. 107.
https://doi.org/10.1186/s12943-017-0671-2
|
[27]
|
Cantarero, L., Moura, D.S., Salzano, M., Monsalve, D.M., Campillo-Marcos, I., Martín-Doncel, E. and Lazo, P.A. (2017) VRK1 (Vaccinia-Related Kinase 1). In: Choi, S., Ed., Encyclopedia of Signaling Molecules, 2nd Edition, Springer Science, New York. https://doi.org/10.1007/978-1-4614-6438-9_561-2
|
[28]
|
Valbuena, A., Sanz-Garcia, M., Lopez-Sanchez, I., Vega, F.M., Lazo, P.A. (2011) Roles of VRK1 as a New Player in the Control of Biological Processes Required for Cell Division. Cellular Signalling, 23, 1267-1272.
https://doi.org/10.1016/j.cellsig.2011.04.002
|
[29]
|
Sanz-Garcia, M., Monsalve, D.M., Sevilla, A. and Lazo, P.A. (2012) Vaccinia-Related Kinase 1(VRK1) is an Upstream Nucleosomal Kinase Required for the Assembly of 53BP1 Foci in Response to Ionizing Radiation-Induced DNA Damage. The Journal of Biological Chemistry, 287, 23757-23768.
https://doi.org/10.1074/jbc.M112.353102
|
[30]
|
Monsalve, D.M., Campillo-Marcos, I., Salzano, M., Sanz-Garcia, M., Cantarero, L., Lazo, P.A. (2016) VRK1 Phosphorylates and Protects NBS1 from Ubiquitination and Proteasomal Degradation in Response to DNA Damage. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1863, 760-769.
https://doi.org/10.1016/j.bbamcr.2016.02.005
|
[31]
|
Salzano, M., Sanz-Garcia, M., Monsalve, D.M., Moura, D.S. and Lazo, P.A. (2015) VRK1 Chromatin Kinase Phosphorylates H2AX and Is Required for Foci Formation Induced by DNA Damage. Epigenetics, 10, 373-383.
https://doi.org/10.1080/15592294.2015.1028708
|
[32]
|
Li, Yang and Li, H. (2020) Circular RNA VRK1 Correlates with Favourable Prognosis, Inhibits Cell Proliferation but Promotes Apoptosis in Breast Cancer. Journal of Clinical Laboratory Analysis, 34, e22980.
https://doi.org/10.1002/jcla.22980
|
[33]
|
Campillo-Marcos, I. and Lazo, P.A. (2019) Olaparib and Ionizing Radiation Trigger a Cooperative DNA-Damage Repair Response That Is Impaired by Depletion of the VRK1 Chromatin Kinase. Journal of Experimental & Clinical Cancer Research, 38, Article No. 203. https://doi.org/10.1186/s13046-019-1204-1
|
[34]
|
Carrion, K., Dyo, J., Patel, V., Sasik, R., Mohamed, S.A., Hardiman, G., et al. (2014) The Long Non-Coding HOTAIR is Modulated by Cyclic Stretch and WNT/beta-CATENIN in Human Aortic Valve Cells and Is a Novel Repressor of Calcification Genes. PLoS ONE, 9, e96577. https://doi.org/10.1371/journal.pone.0096577
|
[35]
|
Yang, G., Zhang, S.H., Gao, F., Liu, Z.Y., Lu, M.J., Peng, S., et al. (2014) Osteopontin Enhances the Expression of HOTAIR in Cancer Cells via IRF1. Biochimica et Biophysica Acta (BBA)—Gene Regulatory Mechanisms, 1839, 837-848. https://doi.org/10.1016/j.bbagrm.2014.06.020
|
[36]
|
Zhang, H.Y., Cai, K., Wang, J., Wang, X.Y., Cheng, K., Shi, F.F., et al. (2014) MiR-7, Inhibited Indirectly by LincRNAHOTAIR, Directly Inhibits SETDB1 and Reverses the EMT of Breast Cancer Stem Cells by Downregulating the STAT3 Pathway. Stem Cells, 32, 2858-2868.
|
[37]
|
Qiu, J.J., Lin, Y.Y., Ye, L.C., Ding, J.X., Feng, W.W., Jin, H.Y., et al. (2014) Overexpression of Long Non-Coding RNA HOTAIR Predicts Poor Patient Prognosis and Promotes Tumormetastasis in Epithelial Ovarian Cancer. Gynecologic Oncology, 134, 121-128. https://doi.org/10.1016/j.ygyno.2014.03.556
|
[38]
|
Liu, X.H., Sun, M., Nie, F.Q., Ge, Y.B., Zhang, E.B., Yin, D.D., et al. (2014) Lnc RNA HOTAIR Functions as a Competing Endogenous RNA to Regulate HER2 Expression by Sponging miR-331-3p in Gastric Cancer. Molecular Cancer, 13, Article No. 92. https://doi.org/10.1186/1476-4598-13-92
|
[39]
|
Prensner, J.R. and Chinnaiyan, A.M. (2011) The Emergence of lncRNAs in Cancer Biology. Cancer Discovery, 1, 391-407. https://doi.org/10.1158/2159-8290.CD-11-0209
|
[40]
|
Prensner, J.R., Iyer, M.K, Alejandro Balbin, O., Dhanasekaran, S.M., Cao, Q., Brenner, J.C., et al. (2011) Transcriptome Sequencing across a Prostate Cancer Cohort Identifies PCAT-1, an Unannotated lncRNA Implicated in Disease Progression. Nature Biotechnology, 29, 742-749. https://doi.org/10.1038/nbt.1914
|
[41]
|
Guo, X.G., Xiao, H.Q., Guo, S.H., Li, J., Wang, Y.X., Chen, J., et al. (2019) Long Noncoding RNA HOTAIR Knockdown Inhibits Autophagy and Epithelial-Mesenchymal Transition through the Wnt Signaling Pathway in Radioresistant Human Cervical Cancer HeLa Cells. Journal of Cellular Physiology, 234, 3478-3489.
https://doi.org/10.1002/jcp.26828
|
[42]
|
Li, J., Yang, S.Q., Su, N., Wang, Y., Yu, J.J., Qiu, H.F., et al. (2016) Overexpression of Long Non-Coding RNA HOTAIR Leads to Chemoresistance by Activating the Wnt/β-Catenin Pathway in Human Ovarian Cancer. Tumour Biology, 37, 2057-2065. https://doi.org/10.1007/s13277-015-3998-6
|
[43]
|
Li, J., Wang, Y., Dong, R.F., Yu, J.J. and Qiu, H.F. (2015) HOTAIR Enhanced Aggressive Biological Behaviors and Induced Radio-Resistance via Inhibiting p21 in Cervical Cancer. Tumor Biology, 36, 3611-3619.
https://doi.org/10.1007/s13277-014-2998-2
|